significantly reduced MPO activity and neutrophil infiltration in the urothelium. In ALOX5 knockout mice, UTI89 and CFT073 inoculation caused four times more IBC than in wild-type mice. Consistent with this, neutrophils were extremely sparse in ALOX5 mice in comparison to the wild-type controls. Additionally, CFT073 were recovered in large numbers from the kidneys of ALOX5 knockout mice, but not from those of wild-type mice.
INTRODUCTION AND OBJECTIVES: Urothelial cells grown as a monolayer cannot recapitulate the differential function of urothelial cells (e.g. apical, intermediate, basal urothelial cells). Lipopolysaccharide (LPS)
has been used as a surrogate for E. coli in study of host response to urinary tract infections. We isolated basal membrane of apical urothelial cells from urothelial tissue for patch clamp studies. We measured potassium channel activities in the apical cell and how the large conductance potassium channel activity changed when the urothelium was exposed to LPS.
METHODS: Female C57BL/6 mice 8 to 12 weeks of age were used. Pure urothelium was dissected out using our published technique. Urothelium was placed luminal side down and umbrella cells were exposed after removing basal and intermediate cells with a glass micropipette (Fig. 1) . Both inside-out and cell attached configurations were used. Urothelium was exposed to 40 mg/ml of LPS for 30 minutes. Blockers of BK (paxilline, iberiotoxin), LPS (polymyxin B), protein kinase A (H89) were also used. RT-PCR was performed to assess expression of BK and LPS-receptors (TLR4, CD14, and MD-2).
RESULTS: Two K conductances were found, 28.3AE1pS and 200.6AE4pS. The 200pS channel was sensitive to intracellular calcium, voltage and blocked with iberiotoxin and paxilline. RT-PCR confirmed presence of BK in urothelium. This suggested that the 200pS channel was the BK channel. LPS significantly increased BK channel activity of NPo from 0.50AE0.13 to 1.62AE0.31 (p<0.001) (Fig. 2) ; this effect was abrogated by polymyxin B (Fig. 2) and H89. TLR4, CD14 and MD-2 mRNAs were expressed only in the urothelium and not lamina propria or detrusor smooth muscle.
CONCLUSIONS: To our knowledge, this is the first time basal membranes of umbrella cells have been patch clamped. LPS significantly increased BK channel activity. This change in apical membrane activity represents an early host urothelial cell response to UTI. While we did not study the downstream results of increased BK activity, it is likely that this would have shown increased urothelial cytokine release. This BK-dependent cytokine release mechanism has been described in macrophages. 
INTRODUCTION AND OBJECTIVES:
The NLRP3 inflammasome has gained recognition for its role in mediating inflammation through its activation of pro-inflammatory cytokines like IL-1b. It has been implicated in diabetic sequelae such as nephropathy, retinopathy, neuropathy, and vasculopathy, and in sterile cystopathy such as hemorrhagic cystitis and bladder outlet obstruction. We hypothesize that the NLRP3 inflammasome is activated in the inflammatory response in diabetic bladder dysfunction (DBD), the most common of all diabetic complications.
METHODS: Ins2 (Akita) diabetic mice and age-matched controls underwent 4hr voiding assays to determine development of early DBD, defined as increased frequency and smaller voided volumes. Inflammation and fibrosis were compared through bladder weights, Evans Blue assay, Masson 0 s trichrome stain, and H&E stain. Active caspase-1, a functional moiety of activated inflammasome, was targeted intracellularly by a fluorescent caspase inhibitor and measured through flow cytometry. Paired geometric mean fluorescence intensity was compared via paired T-test, and all other univariate analysis was performed with ANOVA. Significance was defined as p<.05.
RESULTS: Diabetic mice demonstrated DBD as early as week 11 with increased frequency of voids (p<.01), increased total voided volume (p<.05), and decreased volume per void (p<.05), compared to wild type mice. Inflammasome activation was evident as witnessed by increased active caspase-1 in diabetic mice (Figure 1 ). Diabetic mice also had increased Evans blue extravasation, indicating increased capillary permeability, an early sign of inflammation. Furthermore, diabetic bladders demonstrated hypertrophy compared to wild type bladders (20.6 vs 18.9mg; p¼0.2); however, there was no increase in collagen deposition or histological changes on H&E staining.
CONCLUSIONS: Inflammasomes are activated early in the development of diabetic bladder dysfunction and may contribute to the onset of voiding dysfunction. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e267 INTRODUCTION AND OBJECTIVES: Hemorrhagic cystitis is a highly-morbid inflammatory bladder disease associated with nitrogen mustard alkylating agents, most notably cyclophosphamide. Acrolein, a reactive oxygen species metabolite of cyclophosphamide, has been shown to silence DNA damage repair genes via global methylation pathways. 8-oxoguanine DNA glycosylase (Ogg1) is one such silenced base excision repair enzyme that can restore DNA integrity. Subsequent inflammation from the accumulation of DNA damage results in bladder smooth muscle pyroptotic cell death. We hypothesized that reversing inflammasome-induced imprinting and gene silencing in the bladder smooth muscle could prevent hemorrhagic cystitis.
METHODS: Experiments were carried out using cultured detrusor fibroblasts, B6 wild-type mice, and Ogg1 knockout mice. Hemorrhagic cystitis was induced with either cyclophosphamide or acrolein. Mesna, the current standard of care treatment to prevent hemorrhagic cystitis; Nicotinamide, a vitamin B-3 analog shown to ameliroate bladder inflammation; and suberoylanilide hydroxamic acid, a histone deacetylase (HDAC) inhibitor with anti-inflamatory properties, were added to treatment groups. Harvested tissues and cells were subjected to bisulfite sequencing and chromatin immunoprecipitation analysis to evaluate DNA methylation patterns and epigenetic imprinting.
RESULTS: There was enhanced recruitment of Dnmt1 and Dnmt3b to the Ogg1 promoter in acrolein treated bladder fibroblasts as demonstrated by the pattern of CpG-island methylation and resultant bisulfite sequencing. Accumulation of reactive oxygen species with spontaneous pyroptotic signaling was found in Ogg1 knockout detrusor cells. Suberoylanilide hydroxamic acid restored Ogg1 expression to physiologic levels moreso than either nicotinamide or Mesna in all hemorrhagic cystitis models. Additionally, suberoylanilide hydroxamic acid restored histologically-visible cyclophosphamide-induced bladder damage to that of normal untreated control mice.
CONCLUSIONS: The pattern of epigenetic imprinting induced by inflammation suggests a novel therapeutic target for the treatment of hemorrhagic cystitis. HDAC inhibitors can reactivate Ogg1 expression by altering DNA methylation through Dnmt3B regulation. More broadly, the data suggest that re-programming epigenetic imprinting could limit the inflammatory process induced by not only cyclophosphamide but by a multitude of other toxic insults as well. Clinical unilateral ureteral obstruction (UUO) results from pathologies like ureteral calculi, malignancy, trauma, and periureteral fibrosis. UUO requires prompt surgical intervention to prevent progressive inflammation, fibrosis, and kidney function impairment. Novel therapies are needed to recover renal function and architecture after obstruction. Previous reports show the anti-inflammatory cytokine interleukin-10 (IL-10) attenuates fibrosis in a murine model. We and others have shown IL-10 regulates angiogenesis and endothelial progenitor recruitment during dermal and ischemic cardiac tissue repair. We hypothesize that IL-10 can promote angiogenesis and prevent microvascular rarefaction in a murine UUO model.
METHODS: 8 week-old C57BL/6J (WT) mice and IL-10 null male mice were injected with lenti-IL-10/lenti-GFP (1x10 10 IU) under the renal capsule. Three days after injection, UUO was performed. 14 days after UUO, UUO/sham kidneys and serum were collected for RNA, ELISA and immunohistochemical analysis of VEGF and TGFb isoforms. Primary fibroblasts were isolated from 8-10 week-old male WT mice. IL-10 (50 ng/ml or 200 ng/ml) was added to cultures. VEGF and TGFb-1 gene expressions were assessed by qPCR at 1, 2, 3 and 6h. Levels of TGFb-1 and TGFb-3 were determined at 48h by ELISA. Data presented as meanAESD, n¼3/treatment group. P value by ANOVA.
RESULTS: IL-10 treatment, in vitro, increased VEGF expression (related to physiologic angiogenesis) and altered the expression of TGFb isoforms (related to pathologic fibrosis). Lenti-Il10 treatment in mice with UUO reduced fibrotic changes between tubules (45AE7%, p<0.05) and attenuated tubular dilatation (p<0.05, n¼30/group). CD31, an endothelium marker essential to preserving tubular integrity, was normally expressed in healthy kidney parenchyma and decreased after UUO. IL-10 null mice showed a lower basal level of CD31 than WT mice. In both WT and IL-10 null mice, IL-10 treatment preserved CD31, suggesting a role in rescuing integral peritubular capillaries.
CONCLUSIONS: Ureteral obstruction can cause remodeled renal architecture and decrease in renal function. Our results in a murine UUO model show that IL-10 can effectively promote angiogenesis in vitro and prevent microvascular rarefaction in vivo. Mice treated with IL-10 show decreased fibrotic change and increased markers for tubular integrity. These results from the in vivo studies of UUO, and the in vitro studies of IL-10 0 s influence in angiogenesis and fibrosis of the kidney, may lead to novel treatments for the sequelae of urinary tract obstruction.
